382 related articles for article (PubMed ID: 17079849)
1. [Biochemical markers of bone in steroid (glucocorticoid)-induced osteoporosis (GIOP)].
Masaki H; Miki T
Clin Calcium; 2006 Nov; 16(11):1823-32. PubMed ID: 17079849
[TBL] [Abstract][Full Text] [Related]
2. [Biochemical markers of bone turnover. New aspect. Biochemical bone markers of bone in patients treated with glucocorticoid].
Yamauchi M
Clin Calcium; 2009 Aug; 19(8):1092-1100. PubMed ID: 19638692
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers in glucocorticoid-induced osteoporosis.
Minisola S; Del Fiacco R; Piemonte S; Iorio M; Mascia ML; Fidanza F; Cipriani C; Raso I; Porfiri ML; Francucci CM; D'Erasmo E; Romagnoli E
J Endocrinol Invest; 2008 Jul; 31(7 Suppl):28-32. PubMed ID: 18791348
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of bone health and osteoporosis risk.
Eastell R; Hannon RA
Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
[TBL] [Abstract][Full Text] [Related]
6. [Glucocorticoid-induced osteoporosis].
Tóth M; Tulassay Z
Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
[TBL] [Abstract][Full Text] [Related]
7. [Management of glucocorticoid-induced osteoporosis in childhood].
Tanaka H
Clin Calcium; 2006 Nov; 16(11):1879-86. PubMed ID: 17079856
[TBL] [Abstract][Full Text] [Related]
8. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment].
Tanaka H
Clin Calcium; 2007 Jul; 17(7):1114-9. PubMed ID: 17607080
[TBL] [Abstract][Full Text] [Related]
9. [Biochemical markers of bone remodeling: recent data of their applications in managing postmenopausal osteoporosis].
Bahlous A; Kalai E; Hadj Salah M; Bouzid K; Zerelli L
Tunis Med; 2006 Nov; 84(11):751-7. PubMed ID: 17294906
[TBL] [Abstract][Full Text] [Related]
10. What is new in the treatment of steroid-induced osteoporosis?
Liu RH; Werth VP
Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
[TBL] [Abstract][Full Text] [Related]
11. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
Suzuki Y; Sato S
Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-induced osteoporosis.
Berris KK; Repp AL; Kleerekoper M
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
[TBL] [Abstract][Full Text] [Related]
13. [Modifications of markers of bone resorption in patients affected by glucocorticoid induced osteoporosis (GIOP) treated with neridronate].
Benucci M; Dolenti S; Saviola G; Manfredi M
Recenti Prog Med; 2006 Jan; 97(1):24-7. PubMed ID: 16535926
[TBL] [Abstract][Full Text] [Related]
14. [Management of osteoporosis by using biochemical markers for bone turnover].
Mizunuma H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():227-30. PubMed ID: 18159710
[No Abstract] [Full Text] [Related]
15. [Assessment of bone quality. Bone quality of steroid-induced osteoporosis].
Li M; Saito T; Amizuka N
Clin Calcium; 2008 Mar; 18(3):328-35. PubMed ID: 18310820
[TBL] [Abstract][Full Text] [Related]
16. Effects of bisphosphonate administration on the bone mass in immune thrombocytopenic purpura patients under treatment with steroids.
Nomura S; Kurata Y; Tomiyama Y; Takubo T; Hasegawa M; Saigo K; Nishikawa M; Higasa S; Maeda Y; Hayashi K
Clin Appl Thromb Hemost; 2010 Dec; 16(6):622-7. PubMed ID: 19959489
[TBL] [Abstract][Full Text] [Related]
17. The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.
Korczowska I; Olewicz-Gawlik A; Hrycaj P; Lacki J
Yale J Biol Med; 2003; 76(2):45-54. PubMed ID: 15369631
[TBL] [Abstract][Full Text] [Related]
18. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
Hayakawa N; Suzuki A
Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
[TBL] [Abstract][Full Text] [Related]
19. Prevention of glucocorticoid-induced osteoporosis.
Reid IR; Schooler BA; Stewart AW
J Bone Miner Res; 1990 Jun; 5(6):619-23. PubMed ID: 2200239
[TBL] [Abstract][Full Text] [Related]
20. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
Elwakkad AS; El Elshamy KA; Sibaii H
Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
